{"abdominal distension": 3.19, "abdominal pain": 2.6, "gait inability": 2.33, "hot flush": 9.96, "incorrect dose administered": 4.01, "incorrect route of product administration": 9.49, "injection site abscess": 93.27, "injection site cellulitis": 116.88, "injection site discomfort": 10.2, "injection site erythema": 16.3, "injection site haematoma": 4.88, "injection site haemorrhage": 7.1, "injection site induration": 57.35, "injection site infection": 52.37, "injection site inflammation": 4.44, "injection site mass": 82.76, "injection site nodule": 154.11, "injection site oedema": 21.92, "injection site pain": 6.69, "injection site pruritus": 3.87, "injection site rash": 10.09, "injection site reaction": 8.87, "injection site swelling": 7.15, "injection site urticaria": 12.01, "injection site warmth": 3.06, "pollakiuria": 3.25, "product administered at inappropriate site": 70.76, "prostate cancer": 7.76, "prostatic specific antigen increased": 14.21, "wrong technique in product usage process": 7.28}